文献速递脑血管病

大血管闭塞伴轻度症状卒中血管内治疗结局

Outcome of endovascular therapy in stroke with large vessel occlusion and mild symptoms.
PubMed 文献 · Neurology · 2019-10-07

该回顾性研究基于瑞士卒中登记,比较EVT(±IVT)与单纯IVT在大血管闭塞且NIHSS≤5患者中的结局。倾向评分匹配后每组108例,3个月良好功能结局(mRS 0-1)EVT组63% vs IVT组65.7%(OR 0.94,95%CI 0.51-1.72,p=0.840),结论为两者相似有效,EVT在残疾水平和死亡率上可能略差。

要点

  • 大血管闭塞伴轻度症状患者,EVT与IVT的3个月良好功能结局相似。
  • EVT组死亡率略高(9.3% vs 2.8%,p=0.06),症状性颅内出血均罕见。
  • EVT在全部残疾水平结局和死亡率上可能略逊于IVT,需进一步研究亚组。

核心结论

  • 在大血管闭塞伴轻度神经症状的急性缺血性卒中患者中,EVT与IVT在3个月良好功能结局上似乎同样有效。
  • EVT在全部残疾水平结局和死亡率上可能略逊于IVT。

研究设计与样本

  • 该研究为瑞士卒中登记患者的回顾性分析,纳入入院NIHSS≤5且大血管闭塞的患者。
  • 比较EVT(±IVT)与单纯IVT,共11,356例中312例符合标准,倾向评分匹配后每组108例。

主要发现

  • EVT组与IVT组3个月良好功能结局(mRS 0-1)比例分别为63%和65.7%(OR 0.94,95%CI 0.51-1.72,p=0.840)。
  • EVT组3个月mRS评分有非显著升高趋势(p=0.717)。
  • 两组存活但高残疾(mRS 4-5)比例均很低且相当(p=0.419)。
  • EVT组死亡率略高(9.3% vs 2.8%,p=0.06)。
  • 症状性颅内出血两组均罕见(2.8% vs 0%,p=0.997)。

关键数值与推荐

  • 主要终点为3个月良好功能结局(mRS 0-1)。
  • 次要终点包括独立(mRS 0-2)、mRS序贯移位分析和存活伴高残疾(mRS 4-5)。
  • 安全性终点为死亡率和症状性出血。

临床怎么用

  • 对于大血管闭塞且症状轻微(NIHSS≤5)的急性缺血性卒中患者,EVT与IVT均可考虑,但需权衡EVT可能略高的死亡风险。
  • 具体治疗决策应个体化,并等待进一步研究明确可能获益的亚组。

局限性

  • 本研究为回顾性分析,证据等级为Class III。
  • 匹配后样本量较小(每组108例),可能不足以检测组间微小差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes after endovascular therapy (EVT) and IV thrombolysis (IVT) in patients with stroke with emergent large vessel occlusion (LVO) and mild neurologic deficits. METHODS: This was a retrospective analysis of patients from the Swiss Stroke Registry with admission NIH Stroke Scale score ≤5 and LVO treated by EVT (± IVT) vs IVT alone. The primary endpoint was favorable functional outcome (modified Rankin Scale [mRS] score 0-1) at 3 months. Secondary outcomes were independence (mRS score 0-2), mRS score (ordinal shift analysis), and survival with high disability (mRS score 4-5). Safety endpoints were mortality and symptomatic hemorrhage. RESULTS: Of 11,356 patients, 312 met the criteria and propensity score method matched 108 in each group. A comparably large proportion of patients with EVT and IVT had favorable outcome (63% vs 65.7% respectively; odds ratio 0.94, 95% confidence interval 0.51-1.72; p = 0.840). Patients with EVT showed a nonsignificant trend toward higher mRS score at 3 months (p = 0.717), while the proportion of surviving patients with high disability was comparably very low in both groups (p = 0.419). Mortality was slightly higher among those with EVT (9.3% vs 2.8%; p = 0.06), and symptomatic intracranial hemorrhage was a rare event in both groups (2.8% vs 0%; p = 0.997). CONCLUSIONS: In acute ischemic stroke, EVT and IVT appear similarly effective in achieving favorable outcome at 3 months for patients with LVO and mild neurologic symptoms. EVT might be marginally inferior to IVT regarding outcome across all levels of disability and mortality. Further studies are required to determine whether certain subgroups of patients with LVO and mild symptoms benefit from EVT. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that patients with LVO and mild symptoms receiving either EVT or IVT had similar favorable functional outcomes at 3 months.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Manno C, Disanto G, Bianco G, et al. Outcome of endovascular therapy in stroke with large vessel occlusion and mild symptoms. Neurology. 2019. PMID: 31591276. doi:10.1212/WNL.0000000000008362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。